Report #2840692

Received May 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 51 yrs
State: MI
Recovered: Unknown
Vaccinated: Apr 18, 2025
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	33473	—

Symptoms (1)

Vitreous floaters

Symptom narrative

floaters in his left eye; This non-serious case was reported by a nurse via call center representative and described the occurrence of eye floaters in a male patient who received Herpes zoster (Shingrix) (batch number 33473, expiry date 29-OCT-2026) for prophylaxis. On 18-APR-2025, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced eye floaters (Verbatim: floaters in his left eye). The outcome of the eye floaters was unknown. It was unknown if the reporter considered the eye floaters to be related to Shingrix. It was unknown if the company considered the eye floaters to be related to Shingrix. Additional Information: GSK Receipt Date: 06-MAY-2025 The reporter had been the healthcare professional (nurse) who had stated that a patient had experienced floaters in his left eye after receiving his first dose of Shingrix.